Crosstalk in Met receptor oncogenesis

  • Lai A
  • Abella J
  • Park M
  • 125


    Mendeley users who have this article in their library.
  • 116


    Citations of this article.


The Met receptor tyrosine kinase (RTK) regulates several distinct biological processes, including cell scatter, cell invasion, cell survival and epithelial remodeling. MET is genetically altered through several mechanisms in multiple human cancers; these events are causally related to cancer initiation and progression, identifying Met as a potential therapeutic target. Recent evidence highlights additional roles for Met in cancer through crosstalk with other receptors and cell surface proteins. In this review, we discuss recent progress in our understanding of mechanisms of interaction between Met, the epidermal growth factor receptor family and other cell surface protein families, and how these contribute to signal crosstalk, oncogenesis and drug resistance. © 2009 Elsevier Ltd. All rights reserved.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Andrea Z. Lai

  • Jasmine V. Abella

  • Morag Park

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free